Selected research
Market Structure
Global Tenapanor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Tenapanor market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Tenapanor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Tenapanor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Tenapanor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Tenapanor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Tenapanor include Kyowa Kirin, Fosun Pharma and Ardelyx, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Tenapanor market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Tenapanor and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Tenapanor sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tenapanor market size, projected growth trends, production technologies, key applications, and end-use industries.
Tenapanor Segment by Company
Kyowa Kirin
Fosun Pharma
Ardelyx
Tenapanor Segment by Type
10mg per Tablet
20mg per Tablet
30mg per Tablet
50mg per Tablet
Tenapanor Segment by Application
Irritable Bowel Syndrome with Constipation
Hyperphosphatemia
Other
Tenapanor Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tenapanor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tenapanor and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tenapanor.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Tenapanor market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tenapanor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tenapanor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Tenapanor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 10mg per Tablet
- 20mg per Tablet
- 30mg per Tablet
- 50mg per Tablet
Applications
- Irritable Bowel Syndrome with Constipation
- Hyperphosphatemia
- Other
Companies covered
- Kyowa Kirin
- Fosun Pharma
- Ardelyx
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Tenapanor Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Tenapanor Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Tenapanor Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Tenapanor Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Tenapanor Market Dynamics
- 2.1 Tenapanor Industry Trends
- 2.2 Tenapanor Industry Drivers
- 2.3 Tenapanor Industry Opportunities and Challenges
- 2.4 Tenapanor Industry Restraints
3 Tenapanor Market by Manufacturers
- 3.1 Global Tenapanor Revenue by Manufacturers (2021-2026)
- 3.2 Global Tenapanor Sales by Manufacturers (2021-2026)
- 3.3 Global Tenapanor Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Tenapanor Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Tenapanor Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Tenapanor Manufacturers, Product Type & Application
- 3.7 Global Tenapanor Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Tenapanor Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Tenapanor Players Market Share by Revenue in 2025
- 3.8.3 2025 Tenapanor Tier 1, Tier 2, and Tier 3
4 Tenapanor Market by Type
- 4.1 Tenapanor Type Introduction
- 4.1.1 10mg per Tablet
- 4.1.2 20mg per Tablet
- 4.1.3 30mg per Tablet
- 4.1.4 50mg per Tablet
- 4.2 Global Tenapanor Sales by Type
- 4.2.1 Global Tenapanor Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Tenapanor Sales by Type (2021-2032)
- 4.2.3 Global Tenapanor Sales Market Share by Type (2021-2032)
- 4.3 Global Tenapanor Revenue by Type
- 4.3.1 Global Tenapanor Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Tenapanor Revenue by Type (2021-2032)
- 4.3.3 Global Tenapanor Revenue Market Share by Type (2021-2032)
5 Tenapanor Market by Application
- 5.1 Tenapanor Application Introduction
- 5.1.1 Irritable Bowel Syndrome with Constipation
- 5.1.2 Hyperphosphatemia
- 5.1.3 Other
- 5.2 Global Tenapanor Sales by Application
- 5.2.1 Global Tenapanor Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Tenapanor Sales by Application (2021-2032)
- 5.2.3 Global Tenapanor Sales Market Share by Application (2021-2032)
- 5.3 Global Tenapanor Revenue by Application
- 5.3.1 Global Tenapanor Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Tenapanor Revenue by Application (2021-2032)
- 5.3.3 Global Tenapanor Revenue Market Share by Application (2021-2032)
6 Global Tenapanor Sales by Region
- 6.1 Global Tenapanor Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Tenapanor Sales by Region (2021-2032)
- 6.2.1 Global Tenapanor Sales by Region (2021-2026)
- 6.2.2 Global Tenapanor Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Tenapanor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Tenapanor Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Tenapanor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Tenapanor Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Tenapanor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Tenapanor Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Tenapanor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Tenapanor Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Tenapanor Revenue by Region
- 7.1 Global Tenapanor Revenue by Region
- 7.1.1 Global Tenapanor Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Tenapanor Revenue by Region (2021-2026)
- 7.1.3 Global Tenapanor Revenue by Region (2027-2032)
- 7.1.4 Global Tenapanor Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Tenapanor Revenue (2021-2032)
- 7.2.2 North America Tenapanor Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Tenapanor Revenue (2021-2032)
- 7.3.2 Europe Tenapanor Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Tenapanor Revenue (2021-2032)
- 7.4.2 Asia-Pacific Tenapanor Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Tenapanor Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Tenapanor Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Kyowa Kirin
- 8.1.1 Kyowa Kirin Company Information
- 8.1.2 Kyowa Kirin Business Overview
- 8.1.3 Kyowa Kirin Tenapanor Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Kyowa Kirin Tenapanor Product Portfolio
- 8.1.5 Kyowa Kirin Recent Developments
- 8.2 Fosun Pharma
- 8.2.1 Fosun Pharma Company Information
- 8.2.2 Fosun Pharma Business Overview
- 8.2.3 Fosun Pharma Tenapanor Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Fosun Pharma Tenapanor Product Portfolio
- 8.2.5 Fosun Pharma Recent Developments
- 8.3 Ardelyx
- 8.3.1 Ardelyx Company Information
- 8.3.2 Ardelyx Business Overview
- 8.3.3 Ardelyx Tenapanor Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Ardelyx Tenapanor Product Portfolio
- 8.3.5 Ardelyx Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Tenapanor Value Chain Analysis
- 9.1.1 Tenapanor Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Tenapanor Production Mode & Process
- 9.2 Tenapanor Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Tenapanor Distributors
- 9.2.3 Tenapanor Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst